Table 3.
Lumbar measurements with GAFCHROMIC EBT3 film with gamma analysis utilizing the dose criterion relative to the pixel under analysis method
Treatment Plan | Local γ‐analysis constraints w/ 10% threshold | Treatment Platform | ||||
---|---|---|---|---|---|---|
TomoTherapy | Vero | TrueBeam (Flattened) | TrueBeam (FFF) | CyberKnife | ||
Plan A | 3%/3 mm | 100.0 | 99.9 | 100.0 | 100.0 | 99.5 |
2%/2 mm | 98.7 | 98.3 | 96.3 | 99.5 | 98.9 | |
1%/1 mm | 71.7 | 49.8 | 64.7 | 72.8 | 84.2 | |
Plan B | 3%/3 mm | 100.0 | 99.9 | 100.0 | 100.0 | 96.1 |
2%/2 mm | 99.9 | 96.0 | 97.8 | 98.9 | 93.3 | |
1%/1 mm | 85.5 | 51.3 | 71.7 | 79.7 | 74.3 | |
Plan C | 3%/3 mm | 100.0 | 100.0 | 100.0 | 100.0 | 99.2 |
2%/2 mm | 99.5 | 100.0 | 100.0 | 100.0 | 97.5 | |
1%/1 mm | 77.1 | 47.2 | 81.3 | 79.2 | 53.2 | |
Plan D | 3%/3 mm | 99.5 | 100.0 | 100.0 | 100.0 | 97.5 |
2%/2 mm | 96.7 | 99.8 | 96.2 | 99.6 | 95.1 | |
1%1 mm | 80.7 | 75.5 | 81.8 | 82.1 | 79.6 |